Drug Type Small molecule drug |
Synonyms Compound 2a11(Central China Normal University) |
Target |
Mechanism ALDO inhibitors(Aldolases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H13NOSe |
InChIKeyMCSRHGLYNCIRNI-UHFFFAOYSA-N |
CAS Registry2605897-57-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mycoses | Preclinical | CN | 31 Jan 2022 |